Can donanemab slow Alzheimer’s progression? Does clozapine’s agranulocytosis risk persist beyond the initial treatment period? Can antipsychotics cause both catatonia and neuroleptic malignant syndrome? What is the suicide risk in Parkinson’s disease patients? Can AI predict antidepressant response and remission in major depression?
- Provider:Medical Academy, LLC
- Activity Link: https://psychopharmacologyinstitute.com/publication/quick-take-vol-66-2818?utm_source=PARS+ACCME&utm_medium=PARS+ACCME&utm_campaign=PARS+ACCME
- Start Date: 2024-09-01 05:00:00
- End Date: 2024-09-01 05:00:00
- Credit Details: AMA PRA Category 1 Credit™️: 0.75 hours
- Commercial Support: No
- Activity Type: Enduring Material
- CME Finder Type: Online Learning
- Fee to Participate: Yes
- Measured Outcome: Learner Performance
- Provider Ship: Jointly Provided
- Registration: Limited
Subscribe
Login
0 Comments
Oldest